GenScript
Genscript is the world’s leading biotech company providing life sciences services and products. With gene synthesis, peptide, protein, antibody and preclinical drug development service capabilities, we are internationally recognized as a leading biotech company specializing in fundamental life sciences research and early-phase drug discovery services. As of 2018, more than 30,000 peer-reviewed journal articles cited GenScript’s services and products, making GenScript the most frequently cited biotech company in the world.
Neoantigen Peptide Synthesis Service
GenScript’s Neoantigen Peptide Synthesis Service supports everything from functional screening of neoantigen candidates for TCR therapy to clinical stage vaccine immunogenicity testing.
GenScript saRNA: Amplify Expression, Accelerate Discovery
Unlock prolonged and enhanced gene expression with GenScript’s self-amplifying RNA (saRNA) solutions. . Our ready-to-use saRNA is ideal for vaccine development, gene therapy, and advanced research app...
GenCRISPR Synthetic sgRNA
Accelerate precision gene editing with GenScript's customized synthetic sgRNA, up to 266 nt in length.
Genscript is the world’s leading biotech company providing life sciences services and products. With gene synthesis, peptide, protein, antibody and preclinical drug development service capabilities, we are internationally recognized as a leading biotech company specializing in fundamental life sciences research and early-phase drug discovery services. As of 2018, more than 30,000 peer-reviewed journal articles cited GenScript’s services and products, making GenScript the most frequently cited biotech company in the world.